Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
about
Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerSimulation optimization of PSA-threshold based prostate cancer screening policies.A system for MRI-guided transperineal delivery of needles to the prostate for focal therapy.Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancerTransperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.Watchful waiting for prostate cancer: a review article.Temporal changes in the pathologic assessment of prostate cancer.The role of prevalence in the diagnosis of prostate cancer.Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer.Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen.Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionScreening for prostate cancer: a controversy or fact.Management of rising prostate-specific antigen after a negative biopsy.Prostate saturation biopsy following a first negative biopsy: state of the art.Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.Optimizing safety and accuracy of prostate biopsy.Does true Gleason pattern 3 merit its cancer descriptor?Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer.Registration of prostate histology images to ex vivo MR images via strand-shaped fiducials.Transperineal template-guided prostate biopsy: 10 years of experience.Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men.Upgrading of Gleason score on radical prostatectomy specimen compared to the pre-operative needle core biopsy: an Indian experience.Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol.Three-dimensional nonrigid landmark-based magnetic resonance to transrectal ultrasound registration for image-guided prostate biopsy.Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection.Does prostate specific antigen density correlates with aggressiveness of the prostate cancer?Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.Real-time registration of 3D to 2D ultrasound images for image-guided prostate biopsy.Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.Evaluation of intersession 3D-TRUS to 3D-TRUS image registration for repeat prostate biopsies.Comparison of lesions detected and undetected by template-guided transperineal saturation prostate biopsy.Prostate focused ultrasound focal therapy--imaging for the future.A compact mechatronic system for 3D ultrasound guided prostate interventions.Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category? A comparative analysis.Evaluating the utility of intraprocedural 3D TRUS image information in guiding registration for displacement compensation during prostate biopsy.
P2860
Q26998938-64970A09-7E2D-417E-9FAE-69F19F2F5165Q34149637-B65D2984-2B0B-4063-BB27-05714E8786EDQ34539189-9266A86E-167A-4BC1-84EF-A717D76F88E1Q35262855-0D5C7669-9336-4AAE-B0A7-86E291F5A13BQ35722781-C696B1F2-723F-4633-A82E-CF8A481909B8Q36337195-87F198BD-77E2-44C0-BE65-D89CCE8805F4Q36364398-21151623-BF5E-43F6-BAB7-A89B0BDC25A0Q36520474-CBDA9DD2-DEB5-463A-B369-F21492C09042Q36555644-EC4FB95B-C6E1-40E0-9833-E85F08B4718DQ36918476-A7D4F7A8-67B2-446E-A90D-A3CB6CF73957Q37188997-3A899B01-9F66-4EF5-9BDB-77DA89516F16Q37240462-D0EC651E-7F1B-4732-9DA0-C4CF7C994C0EQ37401554-D4051399-70A4-4681-B241-669FFA7EE8D1Q37700962-45212718-CBCB-4D31-8076-434E57E4CC30Q37803538-2CD3CF31-8287-40B1-98F8-83C25D58EAF2Q37846119-6CDE550D-3699-4F40-AEB4-F3D319566781Q38027698-DDC22C47-FF3D-4F98-8A89-8E5EBFB45ED8Q38178850-A2348BD9-CF14-44B3-82C4-39AA94889ABBQ38430080-CBFF5CB0-A248-44A3-B4B4-5A95D1C32AD1Q38841864-10A32E57-057B-47BF-978B-FB445D60ED24Q38928930-13AA8D04-11C0-45B4-B359-5D565C959182Q39477975-6124BE97-4777-44D2-BABD-A32325E3554FQ40029512-088D3B5F-BE30-4FD6-A46D-C2A362C9D509Q40053295-F986AED9-BAA8-4502-90D5-28A6A9FED9EEQ40244717-A3610A5C-CB78-41CF-A883-34DF0F07BF97Q40450047-104DD8D4-C11C-4F75-B4CF-204222A85F43Q40811341-93CD6CD8-DC2F-4208-BC52-2D1FD8323184Q41901097-50E1961A-51B8-4D95-8177-52010C97C426Q42146775-68570454-08F2-4E73-92FA-65042FC6EDB5Q42413527-D8DD162A-781E-4EB2-8241-74294454F4C2Q42632618-F8F4FD7F-22DD-46C5-95AA-652A0DA4FA22Q45986944-A7A82E18-402C-4A4D-8F9D-676DF1F70BD7Q47781877-4B5E310E-3C75-433C-A73F-CAB5F2ED55E6Q48004090-C11A9235-552C-4EC9-BE44-57AE0C5846B1Q48133237-F7F8C29D-3F2F-49C0-BF7C-F69F776F310BQ48296689-A7191E23-7E9C-44E5-AEDB-815849D294EFQ50244924-E8B64496-1668-48BF-BE0F-956E5C406C56Q50683930-1677D35F-6BA9-4ED8-9DFC-D03C9131A211Q50869484-50131260-B856-4A0A-AFE8-72BB8189513FQ51062171-DE668050-51AF-446D-A0B8-44651286DFC4
P2860
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
@en
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
@nl
type
label
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
@en
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
@nl
prefLabel
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
@en
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
@nl
P2093
P1433
P1476
Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
@en
P2093
Daniel O Scharfstein
H Ballentine Carter
Harriete Sanderson
Jonathan I Epstein
P304
P356
10.1016/J.UROLOGY.2005.03.002
P407
P577
2005-08-01T00:00:00Z